- Home
- BUJA vs XTNT Comparison
BUJA vs XTNT Comparison
Compare BUJA & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUJA
- XTNT
- Stock Information
- Founded
- BUJA 2022
- XTNT N/A
- Country
- BUJA Malaysia
- XTNT United States
- Employees
- BUJA N/A
- XTNT N/A
- Industry
- BUJA Blank Checks
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BUJA Finance
- XTNT Health Care
- Exchange
- BUJA Nasdaq
- XTNT Nasdaq
- Market Cap
- BUJA 55.2M
- XTNT 55.6M
- IPO Year
- BUJA 2023
- XTNT N/A
- Fundamental
- Price
- BUJA N/A
- XTNT $0.37
- Analyst Decision
- BUJA
- XTNT Strong Buy
- Analyst Count
- BUJA 0
- XTNT 1
- Target Price
- BUJA N/A
- XTNT $3.00
- AVG Volume (30 Days)
- BUJA 14.2K
- XTNT 225.5K
- Earning Date
- BUJA 01-01-0001
- XTNT 11-12-2024
- Dividend Yield
- BUJA N/A
- XTNT N/A
- EPS Growth
- BUJA N/A
- XTNT N/A
- EPS
- BUJA 0.25
- XTNT N/A
- Revenue
- BUJA N/A
- XTNT $113,862,000.00
- Revenue This Year
- BUJA N/A
- XTNT $31.82
- Revenue Next Year
- BUJA N/A
- XTNT $13.64
- P/E Ratio
- BUJA $44.25
- XTNT N/A
- Revenue Growth
- BUJA N/A
- XTNT 45.11
- 52 Week Low
- BUJA $10.37
- XTNT $0.33
- 52 Week High
- BUJA $12.18
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- BUJA 93.47
- XTNT 29.03
- Support Level
- BUJA $10.95
- XTNT $0.33
- Resistance Level
- BUJA $11.18
- XTNT $0.39
- Average True Range (ATR)
- BUJA 0.00
- XTNT 0.02
- MACD
- BUJA 0.00
- XTNT 0.00
- Stochastic Oscillator
- BUJA 100.00
- XTNT 46.78
About BUJA Bukit Jalil Global Acquisition 1 Ltd.
Bukit Jalil Global Acquisition 1 Ltd is a blank check company.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.